High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

Background: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. Methods: Patients with osteosarcoma relapsed after standard treatment [methotrexate, doxorubicin, cisplatin +/− ifosfamide (...

詳細記述

書誌詳細
主要な著者: Palmerini, Emanuela, Setola, Elisabetta, Grignani, Giovanni, D’Ambrosio, Lorenzo, Comandone, Alessandro, Righi, Alberto, Longhi, Alessandra, Cesari, Marilena, Paioli, Anna, Hakim, Rossella, Pierini, Michela, Marchesi, Emanuela, Vanel, Daniel, Pignochino, Ymera, Donati, Davide Maria, Picci, Piero, Ferrari, Stefano
フォーマット: Online 論文 テキスト
言語:English
出版事項: MDPI 2020
主題:
Article
オンライン･アクセス:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692098/
https://www.ncbi.nlm.nih.gov/pubmed/33142760
http://dx.doi.org/10.3390/cells9112389

インターネット

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692098/
https://www.ncbi.nlm.nih.gov/pubmed/33142760
http://dx.doi.org/10.3390/cells9112389

類似資料